← FDA Drug Approvals (Drugs@FDA)

SERENTIL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1970-02-27

Drug application

FDA Application #

NDA016774

Application type

New Drug Application

Brand name

SERENTIL

Generic name

Mesoridazine Besylate

Active ingredients

MESORIDAZINE BESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1970-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown